Multiple Primary Malignancies and Human Papilloma Virus Infections

  • Stefania Staibano
  • Massimo Mascolo
  • Lorenzo Lo Muzio
  • Gennaro Ilardi
  • Loredana Nugnes
  • Concetta Dodaro
  • Andrea Renda
  • Gaetano De Rosa
Part of the Updates in Surgery book series (UPDATESSURG)


Patients may develop multiple primary malignancies (MPM) due to the occurrence of many known predisposing factors (i.e. genetic background, environmental factors, hormonal unbalance, and acquired immunosuppression); however, in most cases, no obvious cause of has been found [1–3]. During the last few decades, accumulating evidence has pointed to the involvement of human papillomavirus (HPV) in the development of several neoplastic and preneoplastic lesions of anatomic sites beyond the uterine cervix. In particular, HPV has been associated with squamous cell carcinomas and related precursors in the oral cavity, esophagus, skin, larynx, conjunctiva, paranasal sinuses and bronchus, but even in non-Malpighian-derived tumors, such as urinary bladder carcinoma. At least for a subset of these cases, it has been suggested that exposure to HPV can precede the appearance of cancer by 10 or more years [4, 5]; nonetheless, the true prevalence of HPV DNA in pre-cancerous lesions remains uncertain.


Uterine Cervix Human Papilloma Virus Infection Common Fragile Site Multiple Primary Malignancy Tonsillar Carcinoma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Yamamoto S, Yoshimura K, Ri S et al (2006) The risk of multiple primary malignancies with colorectal carcinoma. Dis Colon Rectum 49:S30–36PubMedCrossRefGoogle Scholar
  2. 2.
    Colangelo LA, Gapstur SM, Gann PH et al (2004) Cigarette smoking and colorectal carcinoma mortality in a cohort with long-term follow-up. Cancer 100:288–293PubMedCrossRefGoogle Scholar
  3. 3.
    Otani T, Iwasaki M, Yamamoto S et al (2003) Alcohol consumption, smoking, and subsequent risk of colorectal cancer in middle-aged and elderly Japanese men and female: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev 12:1492–1500PubMedGoogle Scholar
  4. 4.
    Syrjänen S (2007) Human papillomaviruses in head and neck carcinomas. N Engl J Med 356: 1993–1995PubMedCrossRefGoogle Scholar
  5. 5.
    Mork J, Lie AK, Glattre E et al (2001) Human papillomavirus infection as a risk factor for squamous-cell carcinoma of the head and neck. N Engl J Med 344:1125–1131PubMedCrossRefGoogle Scholar
  6. 6.
    Bosch FX, Lorincz A, Munoz N (2002) The causal relation between human papillomavirus and cervical cancer. J Clin Pathol 55:244–265PubMedGoogle Scholar
  7. 7.
    Wright TC, Schiffman M, Solomon D et al (2004) Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening. Obstet Gynecol 103:304–308PubMedGoogle Scholar
  8. 8.
    Schiffman M, Kjaer SK (2003) Natural history of anogenital human papillomavirus infection and neoplasia. J Natl Cancer Inst Monogr 31:14–19PubMedGoogle Scholar
  9. 9.
    Castellsague X, Munoz N (2003) Cofactors in human papillomavirus carcinogenesis-role of parity, oral contraceptives, and tobacco smoking. J Natl Cancer Inst Monogr 31:20–28PubMedGoogle Scholar
  10. 10.
    Palefsky JM, Holly EA (2003) Immunosuppression and co-infection with HIV. J Natl Cancer Inst Monogr 31:41–46PubMedGoogle Scholar
  11. 11.
    Kreimer AR, Clifford GM, Boyle P et al (2005) Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev 14:467–475PubMedCrossRefGoogle Scholar
  12. 12.
    Polo SE, Yheocharis SE, Klijaieko J et al (2004) CAF-1, a marker of clinical value to distinguish quiescent from proliferative cells. Cancer Res 64:2371–2381PubMedCrossRefGoogle Scholar
  13. 13.
    Staibano S, Mignogna C, Lo Muzio L et al (2007) Chromatin assembly factor-1 (CAF-1) mediated regulation of cells proliferation and DNA repair: a link with the biological behavior of squamous cell carcinoma of the tongue. Histopathology 50:911–919PubMedCrossRefGoogle Scholar
  14. 14.
    Staibano S, Mascolo M, Mancini FP et al (2008) Chromatin Assembly Factor-1 (CAF-1) “a prostate cancer progression marker?” (In press)Google Scholar
  15. 15.
    Staibano S, Mascolo M, Scalvenzi M (2008) Detection of biological profile of cutaneous malignant melanoma by CAF-1 proteins expression. (In press)Google Scholar
  16. 16.
    Staibano S, Mascolo M, Nugnes L et al (2008) CAF-1 and chromatin states in the cervical cancer: is there a correlation?” (In press)Google Scholar
  17. 17.
    Lo Muzio L, Staibano S, Pannone G et al (2001) Expression of the apoptosis inhibitor survivin in aggressive squamous cell carcinoma. Exp Mol Pathol 70:249–254PubMedCrossRefGoogle Scholar
  18. 18.
    Li HP, Leu YW, Chang YS (2005) Epigenetic changes in virus-associated human cancers. Cell Research 15:262–271PubMedCrossRefGoogle Scholar
  19. 19.
    Matsukura T, Sugase M (2001) Relationship between 80 Human papillomavirus genotypes and different grades of cervical intraepithelial neoplasia: Association and causality. Virology 283:139–147PubMedCrossRefGoogle Scholar
  20. 20.
    Woodman CB, Collins SI, Young LS (2007) The natural history of cervical HPV infection: unresolved issues Nat Rev Cancer 7:11–22PubMedCrossRefGoogle Scholar
  21. 21.
    Sedjo RL, Inserra P, Abrahamsen M et al (2002) Human papillomavirus persistence and nutrients involved in the methylation pathway among a cohort of young women. Cancer Epidemiol Biomarkers Prev 11:353–359PubMedGoogle Scholar
  22. 22.
    Kim K, Garner-Hamrick PA, Fisher C et al (2003) Methylation patterns of papillomavirus DNA, its influence on E2 function, and implications in viral infection. J Virol 77:12450–12459PubMedCrossRefGoogle Scholar
  23. 23.
    Badal S, Badal V, Calleya-Macias IE et al (2004) The human papillomavirus-18 genome is efficiently targeted by cellular DNA methylation. Virology 324:483–492PubMedCrossRefGoogle Scholar
  24. 24.
    Turan T, Kalantoni M, Calleya-Macias IE et al (2006) Methylation of the human papillomavirus-18 L1 gene: a biomarker of neoplastic progression? Virology 349:175–183PubMedCrossRefGoogle Scholar
  25. 25.
    Badal V, Chuang LS, Tan EH et al (2004) CpG methylation of human papillomavirus type 16 DNA in cervical cancer cell lines and in clinical specimens: genomic hypomethylation correlates with carcinogenic progression. J Virol 77:6227–6234CrossRefGoogle Scholar
  26. 26.
    Kang GH, Lee S, Kim WH et al (2002) Epstein-Barr virus-positive gastric carcinoma demonstrates frequent aberrant methylation of multiple genes and constitutes CpG island methylator phenotype-positive gastric carcinoma. Am J Pathol 160:787–794PubMedGoogle Scholar
  27. 27.
    Vo QN, Geradts J, Gulley ML et al (2002) Epstein-Barr virus in gastric adenocarcinomas: association with ethnicity and CDKN2A promoter methylation. J Clin Pathol 55:669–675PubMedCrossRefGoogle Scholar
  28. 28.
    Yang B, Guo M, Herman JG et al (2003) Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am J Pathol 163:1101–1107PubMedGoogle Scholar
  29. 29.
    Li X, Hui AM, Sun L et al (2004) P16INK4A hypermethylation is associated with hepatitis virus infection, age, and gender in hepatocellular carcinoma. Clin Cancer Res 10:7484–7489PubMedCrossRefGoogle Scholar
  30. 30.
    Kim NR, Lin Z, Kim KR et al (2005) Epstein-Barr virus and p16INK4A methylation in squamous cell carcinoma and precancerous lesions of the cervix uteri. J Korean Med Sci 20:636–642PubMedCrossRefGoogle Scholar
  31. 31.
    Suzuki M, Toyooka S, Shivapurkar N et al (2005) Aberrant methylation profile of human malignant mesotheliomas and its relationship to SV40 infection. Oncogene 10:1302–1308CrossRefGoogle Scholar
  32. 32.
    Gasco M, Crook T (2003) The p53 network in head and neck cancer. Oral Oncol 39:222–231PubMedCrossRefGoogle Scholar
  33. 33.
    Dong SM, Sun DI, Benoit NE et al (2003) Epigenetic inactivation of RASSF1A in head and neck cancer. Clin Cancer Res 9:3635–3640PubMedGoogle Scholar
  34. 34.
    Torland EC, Myers SL, Persing DH et al (2000) Human papillomavirus type 16 integrations in cervical tumors frequently occur in common fragile sites. Cancer Res 60:5916–5921Google Scholar
  35. 35.
    Thorland EC, Myers SL, Gostout BS et al (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22:1225–1237PubMedCrossRefGoogle Scholar
  36. 36.
    Marsit CJ, McClean MD, Furniss CS et al (2006) Epigenetic inactivation of the SFRP genes is associated with drinking, smoking and HPV in head and neck squamous cell carcinoma. IntJ Cancer 119:1761–1766CrossRefGoogle Scholar
  37. 37.
    Chan AO, Peng JZ, Lam SK et al (2006) Eradication of Helicobacter pylori infection reverses E-cadherin promoter hypermethylation Gut 55:463–468PubMedCrossRefGoogle Scholar
  38. 38.
    Esteller M (2006) Epigenetics provides a new generation of oncogenes and tumour-suppressor genes. Br J Cancer 94:179–183PubMedCrossRefGoogle Scholar
  39. 39.
    Monk BJ, Wiley DJ (2004) Human papillomavirus infections: truth or consequences. Cancer 100:225–227PubMedCrossRefGoogle Scholar
  40. 40.
    Woodman CB Collins S Winter H et al (2001) Natural history of cervical human Papillomavirus infection in young women: a longitudinal cohort study. Lancet 357:1831–1836PubMedCrossRefGoogle Scholar
  41. 41.
    Syrjänen S (2004) HPV infections and tonsillar carcinoma. J Clin Pathol 57:449–455PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • Stefania Staibano
    • 1
  • Massimo Mascolo
    • 1
  • Lorenzo Lo Muzio
    • 1
  • Gennaro Ilardi
    • 1
  • Loredana Nugnes
    • 1
  • Concetta Dodaro
    • 2
  • Andrea Renda
    • 2
  • Gaetano De Rosa
    • 1
  1. 1.Department of Biomorfological and Functional Sciences, Unit of PathologyFederico II UniversityNaplesItaly
  2. 2.Surgical, Anesthesiology-rianimative and Emergency Sciences DepartmentFederico II UniversityNaplesItaly

Personalised recommendations